what is better tirzepatide or retatrutide vs dosage chart: complete comparison guide for every dose Comparing the Big 3, Semaglutide,

Only one in 12 remain on a GLP-1 drug for obesity at three years owenhaskins Jun 26, 2025 2 min read Only 8% of individuals (or one in 12) initiating a glucagon-like peptide-1 (GLP-1) agonist drug for obesity without diabetes continued to do so at three years, according to the latest real-world research from Prime Therapeutics (Prime)

Retatrutide targets three gut hormone receptors, tirzepatide targets two

What to expect with Ozempic Ozempic only needs to be administered once weekly

Here is why this matters for the timeline question

Less Common Side Effects A smaller percentage of users report experiencing symptoms such as headaches, dizziness, fatigue, mild swelling at injection sites, or temporary vision changes

Suggested citation for this survey report : Business Group on Health